Back to discover
Drug

Malaria Vaccines

In clinical development
Emerging researchEarly-to-mid development

Also known as malaria, malaria vaccine.

RxNorm67035
1
Research papers
1
Active clinical trials
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this drug.

Phase-specific climatic sensitivities of under-five malaria in Ghana using epidemic modelling, NB-GAMs and SHAP explainability

Industry2026-08-04Nature — Environmental Sciences

Phase-specific climatic sensitivities of under-five malaria in Ghana using epidemic modelling, NB-GAMs and SHAP explainability

Industry2026-08-04Nature — Climate Sciences

Distant Oceans May Help Predict Malaria Risk in Malawi

Industry2026-07-30AGU Eos

The past and future impact of climate change on childhood malaria in Africa

Industry2026-07-29Nature — Climate Sciences

The past and future impact of climate change on childhood malaria in Africa

Industry2026-07-29Nature News

Nonlinear and lagged climatic drivers of malaria incidence in sub-Saharan Africa using multi-country panel analysis 2015–2024

Industry2026-07-04Nature — Environmental Sciences

Nonlinear and lagged climatic drivers of malaria incidence in sub-Saharan Africa using multi-country panel analysis 2015–2024

Industry2026-07-04Nature — Climate Sciences

Identification of cross-stage, cross-species malaria CD8+ T cell antigens

Industry2026-07-01Nature News

Seeking universal malaria-vaccine targets

Industry2026-07-01Nature News

A Phase II Clinical Study to Assess the Safety, Immunogenicity, and Efficacy of Blood-stage Plasmodium Vivax Malaria Vaccine Candidate PvRII/Matrix-M in Healthy Thai Adults Living in Thailand

Clinical trial2026-03-24Results expected Q4 2027 · ClinicalTrials.gov

Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans.

Research2003-05-25Nature medicine

Profile

Identifiers & mechanism

Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.

Canonical name
Malaria Vaccines
Aliases & brands
malariamalaria vaccine
RxNorm CUI
67035

Clinical trials

1 trials

The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.

Development programme
CLINICALTRIALS.GOV · LIVE REGISTRY
1
registered trials across all phases
1
Active studies
1
Recruiting
PHASE DISTRIBUTIONn = 1
Phase 21

Research activity

1 papers

Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.

Major research themes1
Immunization, Secondary1
Journals, researchers & institutions
Top journals
  • Nature medicine1
Leading researchers
  • Arulanantham N1
  • Blanchard TJ1
  • Brown K1
  • Butcher G1
  • Cummings J1
  • Dunachie S1
  • Everaere S1
  • Flanagan K1
Leading institutions
free-text, unnormalised
  • University of Oxford1
References & data sources
  • RxNorm (U.S. National Library of Medicine) — drug identity
  • Europe PMC — research literature
  • ClinicalTrials.gov — clinical trials